跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
Approvals
/
HSA
/
DOCETAXEL ADVAGEN CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/ML
Approved
THERAPEUTIC
DOCETAXEL ADVAGEN CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/ML
SICHUAN HUIYU PHARMACEUTICAL LTD. (CHINA)
🇸🇬 Health Sciences Authority
Approval Date
Mar 13, 2018
Approval ID
c6fe9205897b517f
Company
SICHUAN HUIYU PHARMACEUTICAL LTD. (CHINA)
Type
Therapeutic
Approval Details
Approval Id
c6fe9205897b517f
Drug Name
DOCETAXEL ADVAGEN CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/ML
Product Name
DOCETAXEL ADVAGEN CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/ML
Approval Number
SIN15449P
Approval Date
2018-03-13
Registrant
ADVAGEN PTE. LTD.
Licence Holder
ADVAGEN PTE. LTD.
Drug Type
Therapeutic
Forensic Classification
PRESCRIPTION ONLY MEDICINES
Dosage Form
INFUSION, SOLUTION CONCENTRATE
Route Of Administration
INTRAVENOUS
Atc Code
L01CD02
Atc Item Name
docetaxel
Pharma Manufacturer Name
ADVAGEN PTE. LTD.
Company Detail Path
/organization/advagen-pte-ltd
Active Ingredients
Docetaxel Anhydrous
20mg/ml
DOCETAXEL ANHYDROUS
20 MG/ML
Approved
Quick Info
Agency
HSA
Country
🇸🇬
Approval Date
Mar 13, 2018
Approval ID
c6fe9205897b517f
Type
Therapeutic
Back to HSA Approvals
DOCETAXEL ADVAGEN CONCENTRATE FOR SOLUTION FOR INFUSION 20MG/ML - HSA Drug Approval Details